News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences
TUCSON, Ariz. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced John Lubniewski, President and CEO of HTG, will present virtually at the H.C.
View HTML
Toggle Summary HTG Introduces Oncology Applications and Expands Analytics Capabilities with Release of New Software Update
TUCSON, Ariz. , Aug. 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commercial release and immediate availability of HTG EdgeSeq Reveal version 3.0, adding additional
View HTML
Toggle Summary HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder
TUCSON, Ariz. , Aug. 14, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder).
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Second Quarter 2020 Results
Call scheduled for today, August 11, at 4:30pm ET TUCSON, Ariz. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2020
View HTML
Toggle Summary HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN
TUCSON, Ariz. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manchester
View HTML
Toggle Summary HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11
TUCSON, Ariz. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2020 after the market close on
View HTML
Toggle Summary HTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications
TUCSON, Ariz. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Reveal RUO oncology applications, which are expected to
View HTML
Toggle Summary HTG Expands RUO Profiling Menu with New NGS Platform Capability Assays
Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platform TUCSON, Ariz. , July 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine,
View HTML
Toggle Summary HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel
TUCSON, Ariz. , July 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch and immediate availability of the HTG EdgeSeq Pan B-Cell Lymphoma Panel in the United States and
View HTML
Toggle Summary HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research Grants
Researchers at University of Pennsylvania Perelman School of Medicine and Charité University Hospitals, Berlin recognized for cutting edge work in autoimmune diseases TUCSON, Ariz. , July 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company
View HTML